Reply

Abstract

HepatologyVolume 37, Issue 2 p. 480-480 CorrespondenceFree Access Reply Ya-Wen Chen, Ya-Wen Chen Ph.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this authorYung-Ming Chen M.D., Yung-Ming Chen M.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this authorShiou-Hwei Yeh, Shiou-Hwei Yeh Ph.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this authorPei-Jer Chen, Pei-Jer Chen M.D., Ph.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this author Ya-Wen Chen, Ya-Wen Chen Ph.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this authorYung-Ming Chen M.D., Yung-Ming Chen M.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this authorShiou-Hwei Yeh, Shiou-Hwei Yeh Ph.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this authorPei-Jer Chen, Pei-Jer Chen M.D., Ph.D. Hepatitis Research Center, Department of Pathology, National Taiwan University Hospital and Division of Molecular and Genomic Medicine, National Health Research Institute, Taipei, TaiwanSearch for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jhep.2003.50059AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002; 36: 927– 935. 2 Chen YJ, Chen PJ, Lee MC, Yeh SH, Hsu MT, Lin CH. Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization. Genes Chromosomes Cancer 2002; 35: 138– 143. 3 Wilkens L, Bredt M, Flemming P, Becker T, Klempnauer J, Kreipe HH. Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2001; 193: 476– 482. 4 Hung CH, Changchien CS, Lu SN, Eng HL, Wang JH, Lee CM, Hsu CC, et al. Sonographic features of hepatic adenomas with pathologic correlation. Abdom Imaging 2001; 26: 500– 506. 5 Wu NH, Wang CC, Huang GT, Yang PM, Sheu JC, Chen DS. A different experience of hepatic adenoma in Taiwan with emphasis on clinical manifestations and ultrasonographic features. Hepatogastroenterology 1999; 46: 3197– 3200. 6 Chie WC, Li CY, Huang CS, Chang KJ, Yen ML, Lin RS. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int J Cancer 1998; 77: 219– 223. 7 Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, Beaudoin JC, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32: 312– 315. Volume37, Issue2February 2003Pages 480-480 ReferencesRelatedInformation